Outset Medical begins selling TabloCart again after FDA nod
Outset Medical (Nasdaq: OM) announced today that the FDA granted 510(k) clearance for its TabloCart with Prefiltration.
Source: massdevice.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Outset Tablo. Real-time updates on events, politics, business and more.